Free Trial

Sean McCutcheon Analyst Performance

Analyst at Raymond James Financial

Sean McCutcheon is a stock analyst at Raymond James Financial in the medical sector, covering 5 publicly traded companies. Over the past year, Sean McCutcheon has issued 5 stock ratings, including strong buy and buy recommendations. While full access to Sean McCutcheon's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean McCutcheon's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 0 Years
Buy Recommendations
100.00% 5 Buy Ratings
Companies Covered
5 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy20.0%1 ratings
Buy80.0%4 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

Out of 5 total stock ratings issued by Sean McCutcheon at Raymond James Financial, the majority (80.0%) have been Buy recommendations, followed by 20.0% Strong Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
5 companies

Sean McCutcheon, an analyst at Raymond James Financial, currently covers 5 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
100.0%

Sean McCutcheon of Raymond James Financial specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
5 companies
100.0%

Sean McCutcheon's Ratings History at Raymond James Financial

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
9/12/2025Initiated Coverage$46.24$72.00Strong-Buy
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
7/11/2025Initiated Coverage$25.61$65.00Outperform
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
7/11/2025Upgrade$5.93$12.00Moderate Buy
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
7/1/2025Upgrade$2.60$9.00Outperform
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
7/1/2025Upgrade$2.48$11.00Outperform